Vitamin premix is projected to hold 17.0% of ingredient type revenue in 2026 and dietary supplements are estimated at 18.0% of application revenue. Manufacturers are favoring controlled blends that reduce dosing work because stability testing and regulatory qualification make supplier changes costly after a formulation enters production.